Colombia's statistics bureau reported the economy grew 3.5% YoY in Q2 2026.

UBS raised its target price for Kelun Botai Bio (06990.HK) to HK$678 from HK$667 and reiterated a Buy rating. UBS said H1 product revenue was 657 mln yuan, above its expectation. The bank lifted EPS forecasts for 2026–28 to 2.41, 2.09 and 8.29 yuan per share and now projects 2026 product revenue of 14.3 bln yuan.

The SFC welcomed the National Financial Regulatory Administration's announcement backing mainland insurance funds' participation in mainland–Hong Kong market connectivity, including support for mainland insurers to invest in HKEX‑listed ETFs via the Shanghai‑Shenzhen‑Hong Kong Stock Connect. The SFC said the policy broadens mainland insurers' offshore asset‑allocation channels through Hong Kong, signals Beijing's commitment to deeper financial opening, and should further promote capital‑market coordination between the mainland and Hong Kong.